Application of hs-CRP in Assessment of Tissue Inflammation Following Implantation of Biodegradable Polymer in Experiment.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 19 09 2024
revised: 14 10 2024
accepted: 16 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Implants made of biodegradable polymers are replaced by regenerating tissues through inflammation. The changes occurring in tissues and the organism are of practical interest for studying the biocompatibility of the material and searching for systemic markers in the blood that reflect inflammation in peri-implantation tissues. The highly sensitive C-reactive protein (hs-CRP) measurements in blood and morphometric studies of tissue surrounding the implant were carried out in the experiment within three months of implantation of a biopolymer consisting of polycaprolactone (PCL) and polytrimethylene carbonate (PTMC). During the first month, tissue inflammation decreased, and the blood level of hs-CRP did not increase. The polymer biotransformation began in the tissues after a month of implantation and was accompanied by inflammation moving deeper into the matrix. Proliferation of inflammatory cells in tissues was reflected in an increase in the hs-CRP level three months after polymer installation. The result achieved confirmed the polymer's bioinertness. The level of hs-CRP in the blood of the animals correlated with the level of inflammation in peri-implantation tissues, reflecting the activity of inflammation in the process of polymer biotransformation. This inflammation protein can be recommended for assessing tissue processes following implantation of biopolymers and their biocompatibility.

Identifiants

pubmed: 39456966
pii: ijms252011183
doi: 10.3390/ijms252011183
pii:
doi:

Substances chimiques

C-Reactive Protein 9007-41-4
Polyesters 0
Polymers 0
Biocompatible Materials 0
polycaprolactone 24980-41-4
polytrimethylene carbonate 31852-84-3
Biomarkers 0
Dioxanes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Igor A Eisenach (IA)

Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, 2 Timakova St., Novosibirsk 630117, Russia.

Galina A Lapii (GA)

Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, 2 Timakova St., Novosibirsk 630117, Russia.

Alexandra K Uzyumova (AK)

Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, 2 Timakova St., Novosibirsk 630117, Russia.

Elena L Lushnikova (EL)

Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, 2 Timakova St., Novosibirsk 630117, Russia.

Victor S Ovchinnikov (VS)

Research Institute of Clinical and Experimental Lymphology, Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 6 Arbuzova, Novosibirsk 630060, Russia.

Anastasia O Solovieva (AO)

Research Institute of Clinical and Experimental Lymphology, Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 6 Arbuzova, Novosibirsk 630060, Russia.

Vasiliy A Naprimerov (VA)

The Federal Research Center Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 10 Prospekt Lavrentyeva, Novosibirsk 630090, Russia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH